CRL shares rose 9.3% to $344.87 on October 21, 2026, extending a rally that brought Charles River Laboratories International Inc.’s year-to-date gain to 72.9%.
Key Takeaways
- Insiders sold $42.9 million in shares over the past 12 months, with no purchases reported.
Table of Contents
- CRL shares approach their 52-week high
- Earnings and valuation multiples
- Insider transactions show selling without buying
CRL shares approach their 52-week high
The price was close to the stock’s 52-week high of $348.95, following an 83.2% gain over the past year. Its low during that period was $146.20.
Earnings and valuation multiples
Charles River was currently unprofitable and cash-flow-negative, with no trailing price-to-earnings ratio available. Its forward P/E was 27.0 times and its five-year median trailing P/E was 25.2 times. Those figures use different earnings bases, limiting a direct comparison.
Insider transactions show selling without buying
Over the preceding 12 months, insiders sold $42.9 million worth of shares and made no purchases.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
